DarioHealth (DRIO) to Release Quarterly Earnings on Wednesday

DarioHealth (NASDAQ:DRIO) is expected to be issuing its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 14th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $7.48 million for the quarter.

DarioHealth Stock Up 7.1%

Shares of DRIO stock opened at $0.75 on Monday. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. DarioHealth has a 1 year low of $0.50 and a 1 year high of $1.93. The firm’s fifty day moving average price is $0.68 and its two-hundred day moving average price is $0.74. The firm has a market capitalization of $31.17 million, a P/E ratio of -0.80 and a beta of 1.55.

Wall Street Analysts Forecast Growth

DRIO has been the topic of several recent research reports. TD Cowen lowered shares of DarioHealth from a “buy” rating to a “hold” rating and lowered their price target for the company from $2.00 to $1.00 in a research note on Wednesday, January 29th. Stifel Nicolaus lowered their price target on shares of DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.